A review of literary sources shows the prevalence of the problem of the development of oxidative stress as a side effect of many pathological processes in animals and humans. It is essential to develop ways and means of its prevention and correction since its correction can be a non-specific therapy in developing many pathological processes.The development of oxidative stress caused deviations in redox processes, the permeability of cellular membranes, and their integrity. Overcoming the effects of oxidative stress requires bio-preparations with high bioavailability, which can stimulate the body's natural antioxidant defense system and neutralize the toxic effects of xenobiotics. Reducing the manifestation of oxidative stress is often adapting the body's natural antioxidant protection system to increase the supply or formation of reactive oxygen species and free radical oxidation products.Macro- and microelements are absorbed by the body of animals and humans mainly through the digestive system. To correct deficiencies of certain elements, mineral, and vitamin-mineral supplements used in the diet, and drugs for parenteral administration - under acute deficiency.Chelates of chemical elements are increasingly used in therapeutic practice, as they are characterized by higher bioavailability compared to organic and inorganic salts of the same elements.The use of compounds with higher bioavailability makes it possible to introduce a smaller amount of the drug in terms of metal, which will avoid the irritating effect and improve the organoleptic indicators, preserving or even enhancing the therapeutic effect. Chelates have a lower irritating effect at the same concentrations as in saline solutions. Therefore, the study of the biochemical mechanisms of action of the drug (in particular, in the correction of oxidative stress) is an urgent issue that prompts us to study it to develop a drug with high bioavailability and confirm its effectiveness
bio-preparations; chelate; magnesium; phosphorus; oxidative stress
[1] Allen, L.H. (2002). Advantages and limitations of iron amino acid chelates as iron fortificants. Nutrition Reviews, 60(7), S18-S45. doi: 10.1301/002966402320285047.
[2] Ammerman, C.B. (2000). Chemical characteristics and relative bioavailability of supplemental organic zinc sources for poultry and ruminants. Journal of Animal Science, 78(8), 2039-2054. doi: 10.2527/2000.7882039x.
[3] Ashmead, S.D. (2001). The chemistry of ferrous bis-glycinate chelate. Archivos Latinoamericanos de Nutricion, 51(1), 7-12. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11688084/.
[4] Barnes, P. J. (2020). Oxidative stress-based therapeutics in COPD. Redox Biology, 33, article number 101544. doi: 10.1016/j.redox.2020.101544.
[6] Breymann, C., Honegger, C., Hösli, I., & Surbek, D. (2017). Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Archives of Gynecology and Obstetrics, 296(6), 1229-1234. doi: 10.1007/s00404-017-4526-2.
[7] Cao, J., Henry, P.R., Guo, R., Holwerda, R.A., Toth, J.P., Littell, R.C., Miles, R.D., &
[8] Case, D.R., Zubieta, J., & P Doyle, R. (2020). The coordination chemistry of bio-relevant ligands and their magnesium complexes. Molecules, 25(14), article number 3172. doi: 10.3390/molecules25143172.
[9] Case, D.R., Zubieta, J., Gonzalez, R., & Doyle, R.P. (2021). Synthesis and chemical and biological evaluation of a glycine tripeptide chelate of magnesium. Molecules, 26(9), article number 2419. doi: 10.3390/molecules26092419.
[10] Chen, Y., Xiong, S., Zhao, F., Lu, X., Wu, B., & Yang, B. (2019). Effect of magnesium on reducing the UV-induced oxidative damage in marrow mesenchymal stem cells. Journal of Biomedical Materials Research Part A, 107(6), 1253-1263. doi: 10.1002/jbm.a.36634.
[11] Durlach, J., Guiet-Bara, A., Pagès, N., Bac, P., & Bara, M. (2005). Magnesium chloride or magnesium sulfate: A genuine question. Magnesium Research, 18(3), 187-192. Retrieved from https://pubmed.ncbi.nlm.nih.gov/16259379/.
[12] Flora, S.J., & Pachauri, V. (2010). Chelation in metal intoxication. International Journal of Environmental Research and Public Health, 7(7), 2745-2788. doi: 10.3390/ijerph7072745.
[13] Fong, J., & Khan, A. (2012). Hypocalcemia: Updates in diagnosis and management for primary care. Canadian Family Physician, 58(2), 158-162. Retrieved from https://pubmed.ncbi.nlm.nih.gov/22439169/.
[14] Fouad, G.T., Evans, M., Sharma, P., Baisley, J., Crowley, D., & Guthrie, N. (2013). A randomized, double-blind clinical study on the safety and tolerability of an iron multi-amino acid chelate preparation in premenopausal women. Journal of Dietary Supplements, 10(1), 17-28. doi: 10.3109/19390211.2012.758217.
[15] Głąb, T.K., & Boratyński, J. (2017). Potential of casein as a carrier for biologically active agents. Topics in Current Chemistry, 375(4), article number 71. doi: 10.1007/s41061-017-0158-z.
[16] Grande, A., Leleu, S., Delezie, E., Rapp, C., De Smet, S., Goossens, E., Haesebrouck, F., van Immerseel, F., & Ducatelle, R. (2020). Dietary zinc source impacts intestinal morphology and oxidative stress in young broilers. Poultry Science, 99(1), 441-453. doi: 10.3382/ps/pez525.
[17] Hax, L.T., Rincón, J., Schneider, A., Pegoraro, L., Franco, C.L., Alves, P.R., Pradieé, J., del Pino, F., & Nunes, C.M. (2019). Effect of butafosfan supplementation during oocyte maturation on bovine embryo development. Zygote, 27(5), 321-328. doi: 10.1017/S0967199419000327.
[18] Hertrampf, E., & Olivares, M. (2004). Iron amino acid chelates. International Journal for Vitamin and Nutrition Research, 74(6), 435-443. doi: 10.1024/0300-9831.74.6.435.
[19] Hybertson, B.M., Gao, B., Bose, S.K., & McCord, J.M. (2011). Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine, 32(4–6), 234-246. doi: 10.1016/j.mam.2011.10.006.
[20] Ibrahim, O., & O’Sullivan, J. (2020). Iron chelators in cancer therapy. Biometals, 33(4–5), 201-215. doi: 10.1007/s10534-020-00243-3.
[21] Jahanian, R., & Rasouli, E. (2015). Effects of dietary substitution of zinc-methionine for inorganic zinc sources on growth performance, tissue zinc accumulation and some blood parameters in broiler chicks. Journal of Animal Physiology and Animal Nutrition, 99(1), 50-58. doi: 10.1111/jpn.12213.
[22] Jeppsen, R.B. (2001). Toxicology and safety of Ferrochel and other iron amino acid chelates. Archivos Latinoamericanos de Nutricion, 51(1), 26-34. Retrieved from https://pubmed.ncbinlm.nih.gov/11688078/.
[23] Kaliaperumal, R., Venkatachalam, R., Nagarajan, P., & Sabapathy, S.K. (2021). Association of serum agnesium with oxoidative stress in the pathogenesis of diabetic cataract. Biological Trace Element Research, 199(8), 2869-2873. doi: 10.1007/s12011-020-02429-9.
[24] Kaliaperumal, R., Venkatachalam, R., Nagarajan, P., & Sabapathy, S.K. (2021). Association of serum agnesium with oxoidative stress in the pathogenesis of diabetic cataract. Biological Trace Element Research, 199(8), 2869-2873. doi: 10.1007/s12011-020-02429-9.
[25] Kamiya, K., Boero, M., Shiraishi, K., & Oshiyama, A. (2006). Enol-to-keto tautomerism of peptide groups. The Journal of Physical Chemistry B, 110(9), 4443-4450. doi: 10.1021/jp056250p.
[26] Kontoghiorghe, C.N., Kolnagou, A., & Kontoghiorghes, G.J. (2015). Phytochelators intended for clinical use in iron overload, other diseases of iron imbalance and free radical pathology. Molecules, 20(11), 20841-20872. doi: 10.3390/molecules201119725.
[27] Kreipe, L., Deniz, A., Bruckmaier, R.M., & van Dorland, H.A. (2011). First report about the mode of action of combined butafosfan and cyanocobalamin on hepatic metabolism in nonketotic early lactating cows. Journal of Dairy Science, 94(10), 4904-4914. doi: 10.3168/jds.2010-4080.
[28] Kwiatkowski, J.L. (2008). Oral iron chelators. Pediatric Clinics of North America, 55(2), 461-482. doi: 10.1016/j.pcl.2008.01.005.
[29] Li, C., Chen, T., & Han, L.B. (2016). Iron-catalyzed clean dehydrogenative coupling of alcohols with P(O)-H compounds: A new protocol for ROH phosphorylation. Dalton Transactions, 45(38), 14893-14897. doi: 10.1039/c6dt02236g.
[30] Li, Q., Dahl, D.B., Vannucci, M., Joo H., & Tsai, J.W. (2014). Bayesian model of protein primary sequence for secondary structure prediction. PloS Оne, 9(10), p. 109832. doi: 10.1371/journal.pone.0109832.
[31] Ma, W.Q., Sun, H., Zhou, Y., Wu, J., & Feng, J. (2012). Effects of iron glycine chelate on growth, tissue mineral concentrations, fecal mineral excretion, and liver antioxidant enzyme activities in broilers. Biological Trace Element Research, 149(2), 204-211. doi: 10.1007/s12011-012-9418-5.
[32] Madende, M., Osthoff, G., Patterton, H.G., Patterton, H.E., Martin, P., & Opperman, D.J. (2015). Characterization of casein and alpha lactalbumin of African elephant (Loxodonta africana) milk. Journal of Dairy Science, 98(12), 8308-8318.
doi: 10.3168/jds.2014-9195.
[33] Matheis, G., Penner, M.H., Feeney, R.E., & Whitaker, J.R. (1983). Phosphorylation of casein and lysozyme by phosphorus oxychloride. Journal of Agricultural and Food Chemistry, 31(2), 379-387. doi: 10.1021/jf00116a049.
[34] Melov, S. (2002). Animal models of oxidative stress, aging, and therapeutic antioxidant interventions. The International Journal of Biochemistry & Cell Biology, 34(11), 1395-1400. https://doi.org/10.1016/s1357-2725(02)00086-9 .
[35] Miner-Williams, W.M., Stevens, B.R., & Moughan, P.J. (2014). Are intact peptides absorbed from the healthy gut in the adult human? Nutrition Research Reviews, 27(2), 308-329. doi: 10.1017/S0954422414000225.
[36] Morais, J.B., Severo, J.S., Santos, L.R., de Sousa, M.S.R., de Oliveira, S.R., de Oliveira, A.R., Cruz, K.J., & de Nascimento M.D. (2017). Role of magnesium in oxidative stress in individuals with obesity. Biological Trace Element Research, 176(1), 20-26. doi: 10.1007/s12011-016-0793-1.
[37] Name, J.J., Vasconcelos, A.R., & Valzachi Rocha Maluf, M.C. (2018). Iron bisglycinate chelate and polymaltose iron for the treatment of iron deficiency anemia: A pilot randomized trial. Current Pediatric Reviews, 14(4), 261-268.
Retrieved from https://pubmed.ncbi.nlm.nih.gov/30280670/.
[38] Nuber, U., van Dorland, H.A., & Bruckmaier, R.M. (2016). Effects of butafosfan with or without cyanocobalamin on the metabolism of early lactating cows with subclinical ketosis. Journal of Animal Physiology and Animal Nutrition, 100(1), 146-155. doi: 10.1111/jpn.12332.
[39] Patent of Ukraine for utility model No. 139707. Veterinary drug “Biophosphomag”. Retrieved from https://base.uipv.org/searchINV/search.php?action=viewdetails&IdClaim=265257.
[40] Pereira, R.A., Silveira, P.A., Montagner, P., Schneider, A., Schmitt, E., Rabassa, V.R., Pfeifer, L.F., del Pino, F.A., Pulga, M.E., & Corrêa, M.N. (2013). Effect of butaphosphan and cyanocobalamin on postpartum metabolism and milk production in dairy cows. Animal: An International Journal of Animal Bioscience, 7(7), 1143-1147. doi: 10.1017/S1751731113000013.
[41] Pineda, O., & Ashmead, H.D. (2001). Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition, 17(5), 381-384. doi: 10.1016/s0899-9007(01)00519-6.
[42] Rafiq, S., Huma, N., Pasha, I., Sameen, A., Mukhtar, O., & Khan, M.I. (2016). Chemical composition, nitrogen fractions and mino aacids profile of milk from different animal species. Asian-Australasian Journal of Animal Sciences, 29(7), 1022-1028. Retrieved from doi: 10.5713/ajas.15.0452.
[43] Rehan, F., Ahemad, N., & Gupta, M. (2019). Casein nanomicelle as an emerging biomaterial – a comprehensive review. Colloids and Surfaces B: Biointerfaces, 179, 280-292. doi: 10.1016/j.colsurfb.2019.03.051.
[44] Robberecht, H., Verlaet, A., Breynaert, A., de Bruyne, T., & Hermans, N. (2020). Magnesium, iron, zinc, copper and selenium status in attention-deficit/hyperactivity disorder (ADHD). Molecules, 25(19), article number 4440.
doi: 0.3390/molecules25194440.
[45] Rollin, E., Berghaus, R.D., Rapnicki, P., Godden, S.M., & Overton, M.W. (2010). The effect of injectable butaphosphan and cyanocobalamin on postpartum serum beta-hydroxybutyrate, calcium, and phosphorus concentrations in dairy cattle. Journal of Dairy Science, 93(3), 978-987. doi: 10.3168/jds.2009-2508.
[46] Rubio-Aliaga, I., & Daniel, H. (2008). Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica, 38(7–8), 1022-1042. doi: 10.1080/00498250701875254.
[47] Rutkowska-Zbik, D., Witko, M., & Fiedor, L. (2013). Ligation of water to magnesium chelates of biological importance. Journal of Molecular Modeling, 19(11), 4661-4667. doi: 10.1007/s00894-012-1459-3.
[48] Shah, N.C., Shah, G.J., Li, Z., Jiang, X.C., Altura, B.T., & Altura, B.M. (2014). Shortterm magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: Relevance to atherogenesis, cardiovascular diseases and aging. International Journal of Clinical and Experimental Medicine, 7(3), 497-514. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992387/.
[49] Shenkin, A. (2006). Micronutrients in health and disease. Postgraduate Medical Journal, 82(971), 559-567. doi: 10.1136/pgmj.2006.047670.
[50] Smith, M.B. (2001). Acyl substitution reactions. In M.B. Smith & J. March (Eds.), Advanced organic chemistry (pp. 1218-1223). New York: Wiley Interscience.
[51] Sproul, G.D. (2020). Evaluation of electronegativity scales. ACS Omega, 5(20), 11585-11594. doi: 10.1021/acsomega.0c00831.
[52] Tarallo, A., Damiano, C., Strollo, S., Minopoli, N., Indrieri, A., Polishchuk, E., Zappa, F., Nusco, E., Fecarotta, S., Porto, C., Coletta, M., Iacono, R., Moracci, M., Polishchuk, R., Medina, D.L., Imbimbo, P., Monti, D.M., de Matteis, M.A., & Parenti, G. (2021). Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease. EMBO Molecular Medicine, 13(11), p. 14434. doi: 10.15252/emmm.202114434.
[53] Thongon, N., & Krishnamra, N. (2011). Omeprazole decreases magnesium transport across Caco-2 monolayers. World Journal of Gastroenterology, 17(12), 1574-1583. doi: 10.3748/wjg. v17.i12.1574.
[54] Thongon, N., & Krishnamra, N. (2012). Apical acidity decreases inhibitory effect of omeprazole on Mg (2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers. Experimental & Molecular Medicine, 44(11), 684-693.
doi: 10.3858/emm.2012.44.11.077.
[55] Udechukwu, M.C., Collins, S.A., & Udenigwe, C.C. (2016). Prospects of enhancing dietary zinc bioavailability with food-derived zinc-chelating peptides. Food & Function, 7(10), 4137-4144. doi: 10.1039/c6fo00706f.
[56] Weiller, M., Alvarado-Rincón, J.A., Jacometo, C.B., Barros, C.C., de Souza, I., Hax, L.T., da Silva, T.C., Mattei, P., Barbosa, A.A., Feijó, J.O., Pereira, R.A., Brauner, C.C., Rabassa, V.R., del Pino, F., & Corrêa, M.N. (2020). Butaphosphan effects on glucose metabolism involve insulin signaling and depends on nutritional plan. Nutrients, 12(6), article number 1856. doi: 10.3390/nu12061856.
[57] Xiong, B., Wang, G., Zhou, C., Liu, Y., Li, J., Zhang, P., & Tang, K. (2018). DCC-assisted direct esterification of phosphinic and phosphoric acids with O-nucleophiles. Phosphorus, Sulfur, and Silicon and the Related Elements, 193(4), 239-244. doi: 10.1080/10426507.2017.1395438.
[58] Yamamoto, M., & Yamaguchi, T. (2007). Causes and treatment of hypomagnesemia. Clinical Calcium, 17(8), 1241-1248. doi: clica070812411248.